Myasthenia gravis: vizsgálatok itt: Olaszország
32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSafety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
- Where
- Bergamo, Bologna, Genoa, Milan, Naples, Pisa, Rome
- Életkor
- 18 év and over
- People
- 59 worldwide
- Run by
- NMD Pharma A/S
See details and how to join2023-507539-40-00 · EU 2023-507539-40-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Where
- Bergamo, Florence, Messina, Milan, Naples, Pavia, Pisa, Rome
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07463521 · EU 2025-524756-54-00 - 3. fázisTaking peopleA Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Where
- Bergamo, Florence, Messina, Milan, Naples, Pavia, Pisa, Rome
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07465289 · EU 2025-524757-14-00 - 3. fázisTaking peopleA Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Where
- Brescia, Milan, Naples, Pavia, Rome
- Életkor
- 18 év and over
- People
- 199 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04951622 · EU 2023-504152-97-00 - 2/3. fázisTaking peopleA Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
- Where
- Milan
- Életkor
- 12 év to 17 év
- People
- 8 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06055959 · EU 2022-502072-23-00 - No phaseTaking peopleHolistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
- Where
- Milan, Pavia, Pisa, Roma
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Ad scientiam
See details and how to joinNCT07323316 - 2. fázisTaking peopleADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- Where
- Bergamo, Milan, Naples, Rome
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- argenx
See details and how to joinNCT07673627 · EU 2025-522939-33-00 - 2/3. fázisCsak meghívásosEvaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
- Where
- Florence, Genoa
- Életkor
- 2 év to 18 év
- People
- 12 worldwide
- Run by
- argenx
See details and how to joinNCT05374590 · EU 2023-507379-23-00 - 3. fázisTaking peopleComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Where
- Milan, Naples, Pisa, Rome
- Életkor
- 18 év to 74 év
- People
- 115 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07217587 · EU 2025-521130-28-00 - 3. fázisTaking peopleA Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Where
- Pisa, Rome
- Életkor
- 18 év to 80 év
- People
- 195 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT07647510 · EU 2026-525298-38-00 - No phaseTaking peopleADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Where
- Bergamo, Milan, Naples
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- argenx
See details and how to joinNCT07294170 - 2. fázisTaking peopleA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Where
- Florence, Rome
- Életkor
- 2 év to 17 év
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT06987539 · EU 2025-520993-20-00 - 3. fázisTaking peopleEfficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Where
- Bergamo, Bologna, Genoa, Milan, Pavia, Rome, Treviso
- Életkor
- 18 év and over
- People
- 264 worldwide
- Run by
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT06463587 · EU 2023-507746-83-00 - 3. fázisCsak meghívásosAn Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
- Where
- Milan
- Életkor
- 12 év to 17 év
- People
- 8 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06435312 · EU 2022-502073-42-00 - 1. fázisNot yet taking people in OlaszországBasket trial for B-cEll driven severe auToimmunE and aLoimmune diseases (chronic Graft vErsUs host diseaSe) treated with anti-CD19 CAR T-cell thErapy
- Where
- Bologna, Rome
- People
- 24
- Run by
- Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
See details and how to join2025-522821-37-00 · EU 2025-522821-37-00 - 2/3. fázisTaking peopleA Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
- Where
- Genoa
- Életkor
- 2 év to 17 év
- People
- 12 worldwide
- Run by
- argenx
See details and how to joinNCT06392386 · EU 2023-506159-12-00 - 2. fázisTaking peopleADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Where
- Bergamo, Milan, Naples, Rome
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- argenx
See details and how to joinNCT07284420 · EU 2025-522492-28-00 - 2. fázisTaking peopleSafety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- Where
- Bergamo, Bologna, Genova, Milan, Naples, Pisa, Roma
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- NMD Pharma A/S
See details and how to joinNCT06414954 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Where
- Bergamo, Bologna, Milan, Naples, Pisa, Rome, Sassari
- Életkor
- 18 év to 80 év
- People
- 231 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07039916 · EU 2024-515979-35-00 - No phaseTaking peoplePANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
- Where
- Milan
- Életkor
- 18 év and over
- People
- 40
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07717281 - No phaseTaking peopleA Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
- Where
- Acquaviva delle Fonti, Ancona, Bari, Bergamo, Bologna, Catanzaro, Florence, Genova, Messina, Milan, Monserrato, Naples, Orbassano, Padova, Pavia, Perugia, Pisa, Rimini, Roma, Salerno, San Giovanni Rotondo, Sassari, Treviso, Verona
- Életkor
- 18 év and over
- People
- 100
- Run by
- argenx
See details and how to joinNCT07595653 - No phaseNot yet taking people in OlaszországThymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis
- Where
- Milan
- Életkor
- 18 év and over
- People
- 40
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07571525 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Rome
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - 4. fázisTaking peopleA Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Where
- Naples, Rome
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07221838 · EU 2025-522555-26-00 - No phaseTaking peopleRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Where
- Milan, Naples
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341